Skip to main content
. 2013 Dec 1;6(6):660–669. doi: 10.1593/tlo.13559

Figure 3.

Figure 3

Quantitative analysis of tumor growth factors using protein array kit and ELISA. AMD3100 treatment resulted in a net decrease in the expression of most proangiogenic factors compared to the vehicle treatment. G-CSF expression was significantly increased after treatment with vatalanib compared to the vehicle-treated tumor. Note the significant decrease of VEGFR2 in vatalanib-treated tumors. *P < .05.